Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Article Type
Date
Availability
1-3 of 3
Keywords: hyperlipoproteinaemia
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Articles
Journal:
Clinical Science
Clin Sci Mol Med (1977) 53 (3): 249–256.
Published: 01 September 1977
...J. Ahlberg; B. Angelin; K. Einarsson; K. Hellström; B. Leijd 1. The duodenal bile acid composition was analysed in 24 control subjects and 107 patients with various types of hyperlipoproteinaemia. A highly significant negative correlation was observed between the proportions of deoxycholic acid...
Articles
Journal:
Clinical Science
Clin Sci Mol Med (1976) 51 (4): 393–397.
Published: 01 October 1976
.... 2. The combined excretion of the neutral steroids (excluding plant sterol and plant sterol metabolites) averaged 1·07 ± 0·13 (± sem) mmol/day in the control subjects ( n = 14). The corresponding values in patients with hyperlipoproteinaemia type IIa ( n = 19), II ( n = 12) and IV ( n = 23) were 0·86...
Articles
Journal:
Clinical Science
Clin Sci Mol Med (1974) 47 (6): 547–557.
Published: 01 December 1974
...P. Clifton-Bligh; N. E. Miller; P. J. Nestel 1. Seven patients with type II hyperlipoproteinaemia were treated with the bile acid-sequestering resin, colestipol (5 g three times daily), after a prolonged period of taking placebo. 2. After 8–9 weeks of treatment, the plasma concentration of the non...